Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM1315MO2
TNBC
Basal B
NU6102
CDK1/2
CDK
10875.147
uM
2.25980
7.82550
-0.9660 -1.0000 0.8845 0.3574
0.9621
0.7554
SUM1315MO2
TNBC
Basal B
NU6102
CDK1/2
CDK
12428.147
uM
4.31060
10.71710
-0.9508 -1.0000 1.2063 0.3108
0.9859
0.6926
SUM1315MO2
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
9044.066
uM
17.21680
31.40520
-0.6165 -1.0000 1.8277 0.1712
0.9561
0.8552
SUM1315MO2
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
7528.066
uM
22.50560
44.30250
-0.3231 -1.0000 1.6221 0.1520
0.9703
1.0258
SUM1315MO2
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
10381.066
uM
16.81440
37.95530
-0.3782 -1.0000 1.3494 0.1873
0.9744
1.4484
SUM1315MO2
TNBC
Basal B
Olomoucine II
CDK1
CDK
12428.147
uM
3.62890
6.03330
-0.9670 -0.9998 2.1608 0.4834
0.9971
0.6926
SUM1315MO2
TNBC
Basal B
Olomoucine II
CDK1
CDK
10875.147
uM
3.34440
5.18440
-0.9484 -0.9640 2.4506 0.4788
0.9986
0.7554
SUM1315MO2
TNBC
Basal B
Omipalisib
PI3K
PI3K
10381.087
uM
0.00950
0.05569
-0.6720 -0.6295 0.4608 0.7970
0.9747
0.8565
SUM1315MO2
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10139.021
uM
11.52390
26.06550
-0.9909 -1.0000 1.3460 0.5022
0.9904
0.8389
SUM1315MO2
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9797.011
uM
14.70390
27.26290
-0.9996 -1.0000 1.7794 0.5022
0.9904
0.5004
SUM1315MO2
TNBC
Basal B
Oxamflatin
HDAC
HDAC
10875.147
uM
2.05390
2.55590
-0.9932 -0.9923 5.0000 0.5106
0.9974
0.7554
SUM1315MO2
TNBC
Basal B
Oxamflatin
HDAC
HDAC
12428.147
uM
2.12860
2.64750
-0.9931 -0.9882 5.0000 0.4864
0.9989
0.6926
SUM1315MO2
TNBC
Basal B
PD 98059
MEK
MAPK
12428.152
uM
inf
inf
0.6663 0.6663 0.0000 0.0645
0.5698
0.8719
SUM1315MO2
TNBC
Basal B
PD 98059
MEK
MAPK
10875.152
uM
inf
1.40660
0.6669 0.5616 0.2100 0.1593
0.5998
0.7465
SUM1315MO2
TNBC
Basal B
PD173074
FGFR1/3
RTK
10381.093
uM
3.27850
4.8590
-0.6231 -0.6510 2.1192 0.2588
0.9925
0.9799
SUM1315MO2
TNBC
Basal B
PD184352
MEK
MAPK
10875.155
uM
inf
0.06510
0.8182 0.8795 4.9994 0.0502
0.6963
0.7421
SUM1315MO2
TNBC
Basal B
PD184352
MEK
MAPK
10875.155
uM
inf
0.06510
0.8182 0.8795 4.9994 0.0502
0.6963
0.7421
SUM1315MO2
TNBC
Basal B
PD184352
MEK
MAPK
12428.155
uM
17.66090
82.23440
0.3075 -1.0000 0.7142 0.1086
0.9658
0.7654
SUM1315MO2
TNBC
Basal B
PD184352
MEK
MAPK
12428.155
uM
17.66090
82.23440
0.3075 -1.0000 0.7142 0.1086
0.9658
0.7654
SUM1315MO2
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
10381.095
uM
inf
inf
0.9036 0.9036 0.0000 0.0459
0.3358
1.2787
SUM1315MO2
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
9044.095
uM
inf
inf
0.8681 0.8681 0.0000 0.1009
0.5260
0.7214
SUM1315MO2
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7528.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8526
SUM1315MO2
TNBC
Basal B
PS-1145
IKK
NFKB
7528.065
uM
inf
inf
0.9471 0.9471 0.0000 0.0539
0.1818
1.1128
SUM1315MO2
TNBC
Basal B
PS-1145
IKK
NFKB
9044.065
uM
inf
inf
0.8636 0.8636 0.0000 -0.0127
0.3821
0.5944
SUM1315MO2
TNBC
Basal B
PS-1145
IKK
NFKB
10381.065
uM
inf
inf
0.8948 0.8948 0.0000 -0.0084
0.4505
1.2390